US Broker Ratings

Nuvalent, Inc. (NUVL): Biotechnology Innovator with a 44% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is garnering significant attention within the biotechnology sector. With a robust market capitalization of..

Molina Healthcare Inc (MOH) Stock Analysis: Potential 20.98% Upside Amid Strong Growth and Analyst Confidence

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is garnering significant attention from investors due to its robust performance metrics and..

Avidity Biosciences, Inc. (RNA) Investor Outlook: An 84% Potential Upside with Innovative Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing investor attention in the biotechnology sector with a promising potential upside of 84.29%, driven by its innovative approach in..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 9.56% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands out in the bustling healthcare sector as a key player in the medical devices industry. With a solid..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unpacking the 76% Potential Upside

Revolution Medicines, Inc. (RVMD), a trailblazer in the biotechnology industry, focuses on the development of innovative therapies targeting RAS-addicted cancers. With a market capitalization of $7.65..

Exact Sciences Corporation (EXAS) Investor Outlook: Exploring a 25.51% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within diagnostics and research, continues to attract investor interest. With a market capitalization..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking the 43% Potential Upside for Investors

For investors with a keen eye on the healthcare sector, Bio-Rad Laboratories, Inc. (NYSE: BIO) represents an intriguing opportunity. With a market capitalization of $6.05 billion,..

Medpace Holdings (MEDP) Stock Analysis: Navigating a 65.83% ROE in the Healthcare Sector

Investors eyeing the healthcare sector often consider companies that exhibit strong financial performance and a robust market presence. Medpace Holdings, Inc. (NASDAQ: MEDP), a clinical contract..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 13.92% Potential Upside in the Medical Devices Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI) is gaining attention in the healthcare sector, particularly among investors seeking opportunities in medical instruments and supplies. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 17.63% Potential Upside Amid Strong Buy Ratings

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, offers a compelling investment opportunity with an impressive potential upside of 17.63%. Amid..

CVS Health Corporation (CVS) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and compelling upside potential. With..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 22.76% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Los Angeles,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 19.49% Potential Upside for Investors

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is garnering attention from individual investors due to its robust potential upside of 19.49%...

Biogen Inc. (BIIB) Stock Analysis: Exploring a 29% Upside Potential in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB) stands as a prominent player in the healthcare sector, particularly within the realm of drug manufacturing. With a market capitalization of $19.51..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking a 59% Potential Upside with Promising CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is drawing attention in the biotechnology sector with its innovative approach to treating central nervous system (CNS) disorders. As the company..

Cytokinetics, Incorporated (CYTK) Stock Report: Unpacking a Potential 124.61% Upside in the Biotech Arena

In the dynamic world of biotechnology, Cytokinetics, Incorporated (NASDAQ: CYTK) emerges as an intriguing player, particularly for investors with an appetite for high-growth potential. With its..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.54% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, is making waves in the stock market with a potential upside of 19.54%. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a Potential 58% Upside in Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is not just about diagnostics and therapeutics; it’s about promising growth potential. With a..

Zoetis Inc. (ZTS) Investor Outlook: Strong Buy Ratings and 14.25% Potential Upside

As an investor considering Zoetis Inc. (ZTS), the global leader in animal health solutions, there are several compelling reasons to keep this stock on your radar...

ICON plc (ICLR) Stock Analysis: A 27.62% Potential Upside Amidst Healthcare Sector Volatility

ICON plc (NASDAQ: ICLR) stands out in the healthcare sector, particularly in the diagnostics and research industry, with an impressive market capitalization of $11.05 billion. Based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds